ClinVar Miner

Submissions for variant NM_003482.4(KMT2D):c.15629A>G (p.Tyr5210Cys)

dbSNP: rs1942587772
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001071132 SCV001236420 likely pathogenic Kabuki syndrome 2019-04-02 criteria provided, single submitter clinical testing This variant has been observed to be de novo in individuals affected with Kabuki syndrome (PMID: 21280141, 29846842). This variant is not present in population databases (ExAC no frequency). This sequence change replaces tyrosine with cysteine at codon 5210 of the KMT2D protein (p.Tyr5210Cys). The tyrosine residue is highly conserved and there is a large physicochemical difference between tyrosine and cysteine. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0").

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.